Experience of therapy for bacterial vaginosis
Objective. To study the efficiency of using clindacin B prolong for the treatment of bacterial vaginosis (BV) concurrent with nonspecific vaginitis in non-pregnant women.Lavrova L.V., Dyagileva N.I., Karpova E.E.
Subjects and methods. The investigation enrolled 32 non-pregnant women of reproductive age (mean age, 27.3+0.7 years), who were diagnosed with BV concurrent with nonspecific vaginitis. All the patients were treated with clindacin B prolong at an intravaginal dose of 5.0 g overnight for 3 days.
Results. After treatment, all the examinees were observed to have clinical improvements and a significant decrease in opportunistic microorganisms.
Conclusion. Clindacin B prolong vaginal cream is quite effective in treating BV associated with nonspecific vulvovaginitis.
Keywords
bacterial vaginosis
nonspecific vulvovaginitis
clindacin B prolong
Supplementary Materials
References
1. Spiegel C.A. Bacterial vaginosis. Rev. Med. Microbiol.2002; 13(2): 43-51.
2. Кира Е.Ф. Бактериальный вагиноз. Практическое руководство. СПб.; 2001. [Kira E.F. Bacterial vaginosis. Practical guidance. St. Petersburg; 2001. (in Russian)]
3. Fredericks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 2005; 353(18): 1889-911.
4. Маклецова С.А., Рябинкина Т.С. Бактериальный вагиноз: видимые горизонты проблемы и перспективы диагностики и лечения бактериального вагиноза: что говорят эксперты. Status Praesens. 2014; 3: 47-57. [Makletsova S.A., Ryabinkina T.S. Bacterial vaginosis: the visible horizons of the problem and the prospects for diagnosis and treatment of bacterial vaginosis: what the experts say. Status Praesens. 2014; 3: 47-57. (in Russian)]
5. Савичева А.М., Рыбина Е.В., Ипатова И.Д. В «дружной» компании. Бактериальный вагиноз и смешанные вагинальные инфекции: возможно ли одно без другого? StatusPraesens. Гинекология, акушерство, бесплодный брак. 2014; 6: 39-46. [Savicheva A.M., Ryibina E.V., Ipatova I.D. In a „friendly” company. Bacterial vaginosis and mixed vaginal infections: is one possible without the other? StatusPraesens. Ginekologiya, akusherstvo, besplodnyiy brak. 2014; 6: 39-46. (in Russian)]
6. Фофанова И.Ю., Прилепская В.Н. Рациональные подходы к терапии бактериального вагиноза. Гинекология. 2013; 15(5): 28-31. [Fofanova I.Yu., Prilepskaya V.N. Rational approaches to therapy of bacterial vaginosis. Ginekologiya. 2013; 15(5): 28-31. (in Russian)]
7. Тютюнник В.Л. Патогенез, диагностика и методы лечения бактериального вагиноза. Фарматека. 2005; 2: 20-4. [Tyutyunnik V.L. Pathogenesis, diagnosis and treatment of bacterial vaginosis. Farmateka. 2005; 2: 20-4. (in Russian)]
8. Савченко Т.Н., Крамарь В.С. Микроэкология влагалища при дисбактериозе. Международный журнал прикладных и фундаментальных исследований. 2011; 5: 109-10. [Savchenko T.N., Kramar V.S. Microecology of the vagina with dysbiosis. Mezhdunarodnyiy zhurnal prikladnyih i fundamentalnyih issledovaniy. 2011; 5: 109-10. (in Russian)]
9. Страчунский Л.С. Антибактериальная терапия. Практическое руководство. М.; 2000. [Strachunskiy L.S. Antibacterial therapy. Practical guidance. Moscow; 2000. (in Russian)]
Received 08.09.2017
Accepted 22.09.2017
About the Authors
Lavrova Larisa Vladimirovna, obstetrician-gynecologist, head of the women’s consultation, Regional Clinical Hospital. 390039, Russia, Ryazan, Internatsionalnaya str. 3aDyagileva Natalia Ivanovna, obstetrician-gynecologist, Regional Clinical Hospital. 390039, Russia, Ryazan, Internatsionalnaya str. 3a
Karpova Ekaterina Evgenevna, obstetrician-gynecologist, Regional Clinical Hospital. 390039, Russia, Ryazan, Internatsionalnaya str. 3a
For citations: Lavrova L.V., Dyagileva N.I., Karpova E.E. Experience of therapy for bacterial vaginosis. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (10): 120-3. (in Russian)
https://dx.doi.org/10.18565/aig.2017.10.120-123
Similar Articles
